Zanamivir Patent Expiration
Zanamivir is Used for preventing influenza. It was first introduced by Glaxosmithkline
Zanamivir Patents
Given below is the list of patents protecting Zanamivir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Relenza | US6294572 | Crystalline N-acetyl neuraminic acid derivatives and process for their preparation |
Dec 15, 2014
(Expired) | Glaxosmithkline |
| Relenza | US5648379 | Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
Jul 15, 2014
(Expired) | Glaxosmithkline |
| Relenza | US5360817 | Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents |
Jul 26, 2013
(Expired) | Glaxosmithkline |
Zanamivir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List